Ajaya Kumar Reka

Ajaya Kumar Reka

UNVERIFIED PROFILE

Are you Ajaya Kumar Reka?   Register this Author

Register author
Ajaya Kumar Reka

Ajaya Kumar Reka

Publications by authors named "Ajaya Kumar Reka"

Are you Ajaya Kumar Reka?   Register this Author

7Publications

213Reads

5Profile Views

Epithelial-mesenchymal transition-associated secretory phenotype predicts survival in lung cancer patients.

Carcinogenesis 2014 Jun 7;35(6):1292-300. Epub 2014 Feb 7.

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA, MS Bioworks, LLC, Ann Arbor, MI 48108, USA, Department of Biostatistics, Rutgers School of Public Health, Piscataway, NJ 08854, USA and Center for Computational Medicine and Bioinformatics and Division of Molecular Medicine and Genetics, University of Michigan, Ann Arbor, MI 48109, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgu041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043235PMC
June 2014

Identifying inhibitors of epithelial-mesenchymal transition by connectivity map-based systems approach.

J Thorac Oncol 2011 Nov;6(11):1784-92

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31822adfb0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196823PMC
November 2011

Molecular cross-regulation between PPAR-γ and other signaling pathways: implications for lung cancer therapy.

Lung Cancer 2011 May 26;72(2):154-9. Epub 2011 Feb 26.

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2011.01.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075310PMC
May 2011

Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition.

Mol Cancer Ther 2010 Dec;9(12):3221-32

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical Center, 4062 BSRB, 109 Zina Pitcher Place, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-10-0570DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044476PMC
December 2010